Wealthfront Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-81,183
Closed -$2.7M – 787
2022
Q2
$2.7M Buy
+81,183
New +$3.45M 0.01% 304
2021
Q4
– Sell
-9,040
Closed -$1.15M – 775
2021
Q3
$1.15M Buy
9,040
+7,164
+382% +$1.04M 0.01% 455
2021
Q2
$312K Buy
+1,876
New +$304K ﹤0.01% 574

Other funds holding TDOC

Wealthfront Advisers's TDOC Position: Q3 2022 in Review

Wealthfront Advisers sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 81,183 shares — an estimated $2.7M sold.

Wealthfront Advisers first reported a position in TDOC in Q2 2021 and held it in 3 quarters. The position peaked at $2.7M in Q2 2022. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Wealthfront Advisers reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Wealthfront Advisers sold 81,183 Teladoc Health shares in Q3 2022, an estimated $2.7M.
  • Wealthfront Advisers first reported a position in Teladoc Health in Q2 2021 and held it in 3 quarters.
  • Wealthfront Advisers's Teladoc Health position peaked at $2.7M in Q2 2022.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Wealthfront Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.